The influence of increasing age on susceptibility of the elderly to tuberculosis

Open Longevity Science

Volumn 6, Issue , 2012, Pages 73-82

  Wang, Shu Hua ^a   Carruthers, Bridget ^a   Turner, Joanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Aging; Immunology; Tuberculosis

Indexed keywords

BCG VACCINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADAPTIVE IMMUNITY; AGE; AGE DETERMINATION; BACTERIAL TRANSMISSION; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; CELL FATE; CELLULAR IMMUNITY; DISEASE PREDISPOSITION; ELDERLY CARE; GERIATRIC PATIENT; HEPATITIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; INFECTION CONTROL; INNATE IMMUNITY; LATENT TUBERCULOSIS; LUNG ALVEOLUS CELL; LUNG TUBERCULOSIS; MOLECULAR RECOGNITION; NEUTROPENIA; NONHUMAN; PATIENT COMPLIANCE; PRIMARY TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; SENESCENCE; SPUTUM ANALYSIS; SPUTUM SMEAR; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; TUBERCULOUS MENINGITIS; TUBERCULOUS OSTEOMYELITIS;

EID: 84863956656     PISSN: None     EISSN: 1876326X     Source Type: Journal    
DOI: 10.2174/1876326X01206010073     Document Type: Review

References (67)

1. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tu-berculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163(9): 1009-21.
2. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72(1): 1-6.
3. WHO. Global tuberculosis control 2010. 2010.
4. CDC. Reported tuberculosis in the United States. 2009.
5. Rajagopalan S. Tuberculosis and aging: a global health problem. Clin Infect Dis 2001; 33(7): 1034-9.
6. Rajagopalan S, Yoshikawa TT. Tuberculosis in long-term-care facilities. Infect Control Hosp Epidemiol 2000; 21(9): 611-5.
7. Rajagopalan S, Yoshikawa TT. Tuberculosis in the elderly. Z Gerontol Geriatr 2000; 33(5): 374-80.
8. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19: 93-129.
9. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009; 27: 393-422.
10. Flynn JL. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 2006; 8(4): 1179-88.
11. Torrelles JB, Schlesinger LS. Diversity in Mycobacterium tubercu-losis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb) 2010; 90(2): 84-93.
12. Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985; 312(23): 1483-7.
13. Ijaz K, Dillaha JA, Yang Z, Cave MD, Bates JH. Unrecognized tuberculosis in a nursing home causing death with spread of tuber-culosis to the community. J Am Geriatr Soc 2002; 50(7): 1213-8.
14. CDC. Prevention and control of tuberculosis in facilities providing long-term care to the elderly. Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR Recomm Rep 1990; 39(RR-10): 7-13.
15. Stout RD, Suttles J. Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev 2005; 205: 60-71.
16. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002; 169(9): 4697-701.
17. van Duin D, Mohanty S, Thomas V, et al. Age-associated defect in human TLR-1/2 function. J Immunol 2007; 178(2): 970-5.
18. Rhoades ER, Orme IM. Similar responses by macrophages from young and old mice infected with Mycobacterium tuberculosis. Mech Ageing Dev 1998; 106(1-2): 145-53.
19. Rottinghaus EK, Vesosky B, Turner J. TLR-2 independent recogni-tion of Mycobacterium tuberculosis by CD11c+ pulmonary cells from old mice. Mech Ageing Dev 2010; 131(6): 405-14.
20. Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol 2003; 171(6): 3128-35.
21. Brightbill HD, Libraty DH, Krutzik SR, et al. Host defense mecha-nisms triggered by microbial lipoproteins through toll-like recep-tors. Science 1999; 285(5428): 732-6.
22. Donnini A, Argentati K, Mancini R, et al. Phenotype, antigen-presenting capacity, and migration of antigen-presenting cells in young and old age. Exp Gerontol 2002; 37(8-9): 1097-112.
23. Herrero C, Sebastian C, Marques L, et al. Immunosenescence of macrophages: reduced MHC class II gene expression. Exp Gerontol 2002; 37(2-3): 389-94.
24. Grubeck-Loebenstein B. Changes in the aging immune system. Biologicals 1997; 25(2): 205-8.
25. Haynes L, Linton PJ, Eaton SM, Tonkonogy SL, Swain SL. Inter-leukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med 1999; 190(7): 1013-24.
26. Haynes L, Eaton SM. The effect of age on the cognate function of CD4+ T cells. Immunol Rev 2005; 205: 220-8.
27. Maglione PJ, Chan J. How B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol 2009; 39(3): 676-86.
28. Turner J, Frank AA, Orme IM. Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells. Infect Immun 2002; 70(8): 4628-37.
29. Cooper AM, Callahan JE, Griffin JP, Roberts AD, Orme IM. Old mice are able to control low-dose aerogenic infections with Myco-bacterium tuberculosis. Infect Immun 1995; 63(9): 3259-65.
30. Turner J, Orme IM. The expression of early resistance to an infec-tion with Mycobacterium tuberculosis by old mice is dependent on IFN type II (IFN-gamma) but not IFN type I. Mech Ageing Dev 2004; 125(1): 1-9.
31. Vesosky B, Flaherty DK, Turner J. Th1 cytokines facilitate CD8-T-cell-mediated early resistance to infection with Mycobacterium tu-berculosis in old mice. Infect Immun 2006; 74(6): 3314-24.
32. Berg RE, Cordes CJ, Forman J. Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur J Immunol 2002; 32(10): 2807-16.
33. Rottinghaus EK, Vesosky B, Turner J. Interleukin-12 is sufficient to promote antigen-independent interferon-gamma production by CD8 T cells in old mice. Immunology 2009; 128(1 Suppl): e679-90.
34. Vesosky B, Rottinghaus EK, Davis C, Turner J. CD8 T cells in old mice contribute to the innate immune response to Mycobacterium tuberculosis via IL-12p70 dependent and antigen independent pro-duction of IFN-{gamma}. Infect Immun 2009; 77(8): 3355-63.
35. Orme IM. Aging and immunity to tuberculosis: increased suscepti-bility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J Immunol 1987; 138(12): 4414-8.
36. Orme IM. Aging and immunity to tuberculosis: prolonged survival of old mice infected with Mycobacterium tuberculosis by adoptive immunization with memory-immune T lymphocytes. Cell Immunol 1989; 118(1): 229-33.
37. Orme IM, Griffin JP, Roberts AD, Ernst DN. Evidence for a defec-tive accumulation of protective T cells in old mice infected with Mycobacterium tuberculosis. Cell Immunol 1993; 147(1): 222-9.
38. Turner J, Frank AA, Brooks JV, Marietta PM, Vesosky B, Orme IM. Tuberculosis in aged gammadelta T cell gene disrupted mice. Exp Gerontol 2001; 36(2): 245-54.
39. Turner J, Orme IM. Identification of altered integrin alpha/beta chain expression on T cells from old mice infected with Mycobac-terium tuberculosis. Exp Gerontol 2002; 37(7): 907-16.
40. Orme IM. The kinetics of emergence and loss of mediator T lym-phocytes acquired in response to infection with Mycobacterium tu-berculosis. J Immunol 1987; 138(1): 293-8.
41. Chiu BC, Stolberg VR, Freeman CM, Chensue SW. Mononuclear phagocyte-derived interleukin-10 suppresses the innate pulmonary granuloma cytokine response in aged mice. Am J Pathol 2007; 171(3): 829-37.
42. Chiu BC, Stolberg VR, Chensue SW. Mononuclear phagocyte-derived IL-10 suppresses the innate IL-12/IFN-gamma axis in lung-challenged aged mice. J Immunol 2008; 181(5): 3156-66.
43. Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmo-nary tuberculosis in mice aerogenically infected with virulent My-cobacterium tuberculosis. Tuber Lung Dis 1997; 78(1): 57-66.
44. Orme IM. A mouse model of the recrudescence of latent tuberculo-sis in the elderly. Am Rev Respir Dis 1988; 137(3): 716-8.
45. Reiley WW, Shafiani S, Wittmer ST, et al. Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuber-culosis infection. Proc Natl Acad Sci USA 2010; 107(45): 19408-13.
46. Komine-Aizawa S, Yamazaki T, Yamazaki T, et al. Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis. Clin Vaccine Immunol 2010; 17(10): 1500-6.
47. Silva CL, Bonato VL, Lima VM, Faccioli LH, Leao SC. Character-ization of the memory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guerin or DNA vaccination. Immunology 1999; 97(4): 573-81.
48. Brooks JV, Frank AA, Keen MA, Bellisle JT, Orme IM. Boosting vaccine for tuberculosis. Infect Immun 2001; 69(4): 2714-7.
49. Ito T, Takii T, Maruyama M, et al. Effectiveness of BCG vaccina-tion to aged mice. Immun Ageing 2010; 7: 12.
50. Perez-Guzman C, Vargas MH, Torres-Cruz A, Villarreal-Velarde H. Does aging modify pulmonary tuberculosis? A meta-analytical review. Chest 1999; 116(4): 961-7.
51. Van den Brande P, Vernies T, Verwerft J, Van Bleyenber R, Vanhoenacker F, Demedts M. Impact of age and radiographic presentation on the presumptive diagnosis of pulmonary tuberculo-sis. Respir Med 2002; 96(12): 979-83.
52. Leung CC, Yew WW, Chan CK, et al. Tuberculosis in older peo-ple: a retrospective and comparative study from Hong Kong. J Am Geriatr Soc 2002; 50(7): 1219-26.
53. Wang CS, Chen HC, Yang CJ, et al. The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection 2008; 36(4): 335-40.
54. Lee JH, Han DH, Song JW, Chung HS. Diagnostic and therapeutic problems of pulmonary tuberculosis in elderly patients. J Korean Med Sci 2005; 20(5): 784-9.
55. Morris CD. Pulmonary tuberculosis in the elderly: a different dis-ease? Thorax 1990; 45(12): 912-3.
56. CDC. Guide to the application of genotyping to tuberculosis pre-vention and control. Atlanta, GA: US Department of Health and Health Services 2004.
57. Castle SC, Norman DC, Perls TT, Chang MP, Yoshikawa TT, Makinodan T. Analysis of cutaneous delayed-type hypersensitivity reaction and T cell proliferative response in elderly nursing home patients: an approach to identifying immunodeficient patients. Ger-ontology 1990; 36(4): 217-29.
58. Dorken E, Grzybowski S, Allen EA. Significance of the tuberculin test in the elderly. Chest 1987; 92(2): 237-40.
59. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54(RR-15): 49-55.
60. Kobashi Y, Mouri K, Yagi S, et al. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tubercu-losis. Chest 2008; 133(5): 1196-202.
61. Leung CC, Yam WC, Yew WW, et al. Comparison of T-Spot.TB and tuberculin skin test among silicotic patients. Eur Respir J 2008; 31(2): 266-72.
62. CDC. Treatment of tuberculosis. MMWR Morb Mortal Wkly Rep 2003; 53(RR11): 1-77.
63. Kopanoff DE, Snider DE, Jr., Caras GJ. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117(6): 991-1001.
64. Pande JN, Singh SP, Khilnani GC, Khilnani S, Tandon RK. Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study. Thorax 1996; 51(2): 132-6.
65. Chan CH, Or KK, Cheung W, Woo J. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin. J Med 1995; 26(1-2): 43-52.
66. Mackay AD, Cole RB. The problems of tuberculosis in the elderly. Q J Med 1984; 53(212): 497-510.
67. Stead WW, To T, Harrison RW, Abraham JH, 3rd. Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. Ann Intern Med 1987; 107(6): 843-5.